A pan-immunotherapy signature to predict intratumoral CD8+ T cell expansions

23

A pan-immunotherapy signature to predict intratumoral CD8+ T cell expansions

Tags:

Previous Article

Microbial biopolymers from industrial wastewaters

Pan-immunotherapy biomarker for treatment monitoring

Related Posts

BH3 mimetic therapies for CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia

BH3 mimetic therapies for CBFA2T3::GLIS2 pediatric acut...

51

High-frequency oscillations in epileptic and non-epileptic Alzheimer's disease patients and the differential effect of levetiracetam on the oscillations

High-frequency oscillations in epileptic and non-epilep...

82

E3 ubiquitin ligases in signaling, disease, and therapeutics

E3 ubiquitin ligases in signaling, disease, and therape...

34